Agile Therapeutics to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call and Provide Corporate and Twirla Commercial Updates on Monday, March 1, 2021
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, will release its fourth quarter and full year 2020 financial results on March 1, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, will release its fourth quarter and full year 2020 financial results on March 1, 2021, after market close. A conference call and webcast are scheduled for 4:30 p.m. ET the same day to discuss the results and provide a business update. The company offers innovative contraceptive solutions, including Twirla®, a non-daily prescription contraceptive patch. Investors can access the call via the company's Investor Relations page.
Positive
- Scheduled financial results presentation may indicate transparency and investor engagement.
- Focus on innovative contraceptive solutions could enhance market potential.
Negative
- No specific financial metrics provided in advance; uncertainty over the fourth quarter performance.
Details
News Market Reaction – AGRX
The recorded move for AGRX in the trading session of this news was +1.52%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live Conference Call and Webcast at 4:30 p.m. ET
PRINCETON, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced it will report fourth quarter and full year 2020 financial results after the market close on Monday, March 1, 2021. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.
Investors and other interested parties may participate by registering for a teleconference line or live webcast link in the Events and Presentations section of the Investor Relations page at https://ir.agiletherapeutics.com/events-and-presentations, or by clicking here.
Please log in approximately 10 minutes prior to the scheduled start time. The archived webcast will be available in the Events and Presentations section of the company's website.
About Agile Therapeutics, Inc.
Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.
Follow Agile on LinkedIn and Twitter: @AgileTher.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.